
Aflibercept 8 mg for RVO-Related Macular Edema Submitted in Japan
Bayer Submits Application in Japan for Aflibercept 8 mg to Treat Macular Edema Following Retinal Vein Occlusion Bayer, a global pharmaceutical leader, has formally submitted a regulatory application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for the approval…












